Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00780429|
Recruitment Status : Unknown
Verified October 2008 by IRCCS Policlinico S. Matteo.
Recruitment status was: Active, not recruiting
First Posted : October 27, 2008
Last Update Posted : October 27, 2008
Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy).
Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||54 participants|
|Official Title:||Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months|
|Study Start Date :||June 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00780429
|IRCCS Fondazione Policlinico San Matteo|
|Pavia, Italy, 27100|